Unexplained Weight Gain
Also known as: Adiposity Increase · Body Composition Shift
Unexplained weight gain — particularly visceral and accelerated — is rarely a caloric story alone. It commonly maps to insulin resistance, perimenopausal estradiol shifts, low testosterone, thyroid dysfunction, or sleep loss.
What you need to know
Adult body composition is hormonally and metabolically governed. Sudden or accelerated weight gain in midlife is a biomarker pattern, not a willpower verdict. The standardized panel surfaces the actual driver: fasting insulin, A1C, lipids, ApoB, hs-CRP, testosterone (men), estradiol/progesterone (women), and thyroid. Interventions then map to the driver — GLP-1 receptor agonists for insulin-resistance-dominant cases, hormone optimization for perimenopausal cases, thyroid recalibration where indicated.
How this entity relates
Every entity in the oMeds knowledge graph cross-links to the conditions, biomarkers, medications, and educational surfaces it touches.
Underlying conditions
- Metabolic Syndrome
- Insulin Resistance
- Obesity
- Perimenopause
- Menopause
- Low Testosterone
- Hypothyroidism
- Hashimoto's Thyroiditis
- Type 2 Diabetes
- Prediabetes
- Dyslipidemia
- Non-Alcoholic Fatty Liver Disease (NAFLD)
- Polycystic Ovary Syndrome (PCOS)
- Adrenal Insufficiency
- Cushing Syndrome
- Subclinical Hypothyroidism
- Uterine Fibroids
- Metabolic Dysfunction-Associated Steatohepatitis
- Hypertriglyceridemia
- Leptin Resistance
Diagnostic biomarkers
Bring this entity into your optimization pathway
Every condition, symptom, biomarker, and medication on oMeds is reviewed by a licensed provider and recalibrated against the standardized biomarker panel.

